How to Tell Someone That She Is Dying
“How to Tell Someone That She Is Dying” – The New Yorker
“How to Tell Someone That She Is Dying” – The New Yorker
Shutterstock Legalizing medical marijuana is controversial. Physicians have not always prescribed controlled substances wisely, as a look at our narcotic epidemic confirms. But marijuana is much safer than narcotics and, according to a recent study, might even save us money, by reducing people’s need for other, often more expensive medications. Most notably, marijuana can be…
Cancer drugs have become increasingly expensive in recent years. No one blinks anymore when a new lung cancer or colon cancer treatment comes to market priced at more than $100,000 per patient. In part, we don’t blink because we have simply gotten used to such prices – the shock has worn off. Moreover, many of…
How is a physician supposed to know which medicine is most affordable under which insurance plan?
Fortunately, there are tools coming into use designed to help clinicians figure out patient-specific costs of any medication they prescribe. The tools (jargon alert!) are called RTBTs, for real-time benefit tools.
The COVID-19 virus is wreaking havoc on healthcare providers. Hospitals and outpatient practices are struggling from a combination of lost revenue, from people delaying or canceling appointments, and increased expenses, related to the measures they are taking to reduce the spread of the virus within healthcare settings. As always, when American healthcare providers are in…
In the aftermath of the Parkland High School shooting, we are having lots of debates about the role of the NRA in shaping gun legislation. Politicians who take money from the NRA are said to be in the organization’s pockets. But don’t forget where the NRA gets its money: gun manufacturers. And while no manufacturer…
“Specialty drugs” – that’s what they’re called. Not the pills of old, these pharmaceuticals are often given intravenously or through injection. Often more biologic in their synthesis than chemical, they are expensive to produce and often target narrow disease processes, meaning the number of patients likely to benefit from them is much much smaller than,…